PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-Aug-2022 GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2022 Businesswire
03-Aug-2022 Heather Knight Joins Channel Medsystems Board of Directors Businesswire
03-Aug-2022 ANI Pharmaceuticals Announces the Launch of Acebutolol Hydrochloride Capsules USP Businesswire
03-Aug-2022 Merck Provides Update on Phase 3 KEYNOTE-921 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer Businesswire
03-Aug-2022 Global Cancer Therapies Market Research Report 2022 - ResearchAndMarkets.com Businesswire
03-Aug-2022 AmerisourceBergen Reports Fiscal 2022 Third Quarter Results Businesswire
03-Aug-2022 India Generic Drugs Market Research Report 2022: Small Molecule Generics v/s Biosimilars - Forecast to 2028 - ResearchAndMarkets.com Businesswire
03-Aug-2022 United Therapeutics Corporation Reports Second Quarter 2022 Financial Results Businesswire
03-Aug-2022 Biodesix to Present at the Canaccord Genuity 42nd Annual Growth Conference Businesswire
03-Aug-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-Aug-2022 Global Pharmaceutical Logistics Market Research Report 2022: Need for Pharmaceutical Shipments to Be Treated With the Utmost Care and Meet Certain Regulatory Requirements Driving Growth - ResearchAndMarkets.com Businesswire
03-Aug-2022 Global Artificial Intelligence in Healthcare Diagnosis Market Research Report 2022: Rising Adoption of Healthcare Artificial Intelligence in Research Areas Boosting Sector Growth - ResearchAndMarkets.com Businesswire
03-Aug-2022 SpectrumX Partners With Leading UK Specials Group to Accelerate Production of Anti-Pathogenic Drug for Clinical Trials Businesswire
03-Aug-2022 U.S. Food and Drug Administration (FDA) Approves FYB201/CIMERLITM* (ranibizumab-eqrn), the First and Only Biosimilar Interchangeable with Lucentis®** B3C newswire
03-Aug-2022 PD-1/PD-L1 inhibitors Market value of US$ 43.7 Billion in the year 2022 MARKITWIRED
03-Aug-2022 Electronic Stethoscope Market is projected to reach a valuation around US$ 369 Million in 2029 MARKITWIRED
03-Aug-2022 Surface Plasmon Resonance Market is expected to be valued at US$ 910.4 Million in 2022 MARKITWIRED
03-Aug-2022 Over-The-Counter (OTC) Veterinary Drugs Market reach US$ 18.14 Bn by the end of 2032 MARKITWIRED
03-Aug-2022 IVD Antibodies Market reaching a valuation of nearly US$ 77 Billion by 2027 MARKITWIRED
03-Aug-2022 Pedicle Screw Systems Market is expected to increase at a CAGR of ~4.6% during the forecast period of 2022-2029 MARKITWIRED